The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
Keyword(s):
We investigated the off-patent biological market in Belgium from a policy maker’s perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus, to the overwhelming innovator’s reach and to a concertation model with assessment and appraisal being mixed which results in poorly effective policy measures.
Keyword(s):
2021 ◽
Vol 54
(1)
◽
pp. 37-77
1998 ◽
Vol 28
(1)
◽
pp. 29-46
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 4
(1)
◽
pp. 189-202